Tavitian B - Search Results

1

Reduced PBR/TSPO expression after minocycline treatment in a rat model of focal cerebral ischemia: a PET study using [(18)F]DPA-714.

Martín A, Boisgard R, Kassiou M, Dollé F, Tavitian B. Martín A, et al. Among authors: tavitian b. Mol Imaging Biol. 2011 Feb;13(1):10-5. doi: 10.1007/s11307-010-0324-y. Mol Imaging Biol. 2011. PMID: 20383592

2

Machine Learning of Multi-Modal Tumor Imaging Reveals Trajectories of Response to Precision Treatment.

Mansouri N, Balvay D, Zenteno O, Facchin C, Yoganathan T, Viel T, Herraiz JL, Tavitian B, Pérez-Liva M. Mansouri N, et al. Among authors: tavitian b. Cancers (Basel). 2023 Mar 14;15(6):1751. doi: 10.3390/cancers15061751. Cancers (Basel). 2023. PMID: 36980637 Free PMC article.

3

Characterization of a synthetic anionic vector for oligonucleotide delivery using in vivo whole body dynamic imaging.

Tavitian B, Marzabal S, Boutet V, Kühnast B, Terrazzino S, Moynier M, Dollé F, Deverre JR, Thierry AR. Tavitian B, et al. Pharm Res. 2002 Apr;19(4):367-76. doi: 10.1023/a:1015133205457. Pharm Res. 2002. PMID: 12033366

4

Labelled oligonucleotides as radiopharmaceuticals: pitfalls, problems and perspectives.

Younes CK, Boisgard R, Tavitian B. Younes CK, et al. Among authors: tavitian b. Curr Pharm Des. 2002;8(16):1451-66. doi: 10.2174/1381612023394467. Curr Pharm Des. 2002. PMID: 12052206 Review.

5

A new animal model for the imaging of melanoma: correlation of FDG PET with clinical outcome, macroscopic aspect and histological classification in Melanoblastoma-bearing Libechov Minipigs.

Boisgard R, Vincent-Naulleau S, Leplat JJ, Bouet S, Le Chalony C, Tricaud Y, Horak V, Geffrotin C, Frelat G, Tavitian B. Boisgard R, et al. Among authors: tavitian b. Eur J Nucl Med Mol Imaging. 2003 Jun;30(6):826-34. doi: 10.1007/s00259-003-1152-y. Epub 2003 Apr 8. Eur J Nucl Med Mol Imaging. 2003. PMID: 12682788

6

Modulation of the pharmacokinetic properties of PNA: preparation of galactosyl, mannosyl, fucosyl, N-acetylgalactosaminyl, and N-acetylglucosaminyl derivatives of aminoethylglycine peptide nucleic acid monomers and their incorporation into PNA oligomers.

Hamzavi R, Dolle F, Tavitian B, Dahl O, Nielsen PE. Hamzavi R, et al. Among authors: tavitian b. Bioconjug Chem. 2003 Sep-Oct;14(5):941-54. doi: 10.1021/bc034022x. Bioconjug Chem. 2003. PMID: 13129397

7

Design and synthesis of a new [18F]fluoropyridine-based haloacetamide reagent for the labeling of oligonucleotides: 2-bromo-N-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]acetamide.

Kuhnast B, de Bruin B, Hinnen F, Tavitian B, Dollé F. Kuhnast B, et al. Among authors: tavitian b. Bioconjug Chem. 2004 May-Jun;15(3):617-27. doi: 10.1021/bc049979u. Bioconjug Chem. 2004. PMID: 15149190

8

In vivo biodistribution and pharmacokinetics of 18F-labelled Spiegelmers: a new class of oligonucleotidic radiopharmaceuticals.

Boisgard R, Kuhnast B, Vonhoff S, Younes C, Hinnen F, Verbavatz JM, Rousseau B, Fürste JP, Wlotzka B, Dollé F, Klussmann S, Tavitian B. Boisgard R, et al. Among authors: tavitian b. Eur J Nucl Med Mol Imaging. 2005 Apr;32(4):470-7. doi: 10.1007/s00259-004-1669-8. Epub 2004 Dec 22. Eur J Nucl Med Mol Imaging. 2005. PMID: 15614506

9

1-[3-(2-[18F]fluoropyridin-3-yloxy)propyl]pyrrole-2,5-dione: design, synthesis, and radiosynthesis of a new [18F]fluoropyridine-based maleimide reagent for the labeling of peptides and proteins.

de Bruin B, Kuhnast B, Hinnen F, Yaouancq L, Amessou M, Johannes L, Samson A, Boisgard R, Tavitian B, Dollé F. de Bruin B, et al. Among authors: tavitian b. Bioconjug Chem. 2005 Mar-Apr;16(2):406-20. doi: 10.1021/bc0497463. Bioconjug Chem. 2005. PMID: 15769096

10

Evaluation of drug penetration into the brain: a double study by in vivo imaging with positron emission tomography and using an in vitro model of the human blood-brain barrier.

Josserand V, Pélerin H, de Bruin B, Jego B, Kuhnast B, Hinnen F, Ducongé F, Boisgard R, Beuvon F, Chassoux F, Daumas-Duport C, Ezan E, Dollé F, Mabondzo A, Tavitian B. Josserand V, et al. Among authors: tavitian b. J Pharmacol Exp Ther. 2006 Jan;316(1):79-86. doi: 10.1124/jpet.105.089102. Epub 2005 Oct 6. J Pharmacol Exp Ther. 2006. PMID: 16210395

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

144 results

Search Page

Filters